Golimumab Subcutaneous and Insulin degludec Subcutaneous
Determining the interaction of Golimumab Subcutaneous and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Insulin detemir
- Golimumab Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Golimumab Subcutaneous-Insulin Detemir (Vials)
- Golimumab Subcutaneous-Insulin detemir Subcutaneous
- Golimumab Subcutaneous-Insulin glargine
- Golimumab Subcutaneous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-GoLYTELY
- Insulin degludec Subcutaneous-Gonadorelin
- Insulin degludec Subcutaneous-Gonadorelin Intravenous, Injection
- Insulin degludec Subcutaneous-Gonadotropin, Chorionic
- Insulin degludec Subcutaneous-Gonal-F
- Insulin degludec Subcutaneous-Gonal-f RFF